Targeted Oncology

FDA Expands Approval of Aptima HPV Assay for Cervical Cancer Primary Screening

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Medical Device Network on MSN

Hologic’s Aptima assay secures FDA approval for HPV primary screening

With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...
Rutland Herald

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding ...

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...
Nasdaq

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option ...

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even though it is highly treatable if caught early.2 The American Cancer Society estimates that more than 150,000 ...
Healio

Lack of primary care clinician a barrier to lung cancer screening

Please provide your email address to receive an email when new articles are posted on . Lack of a primary care provider may hinder an individual’s ability to undergo lung cancer screening, according ...
Business Wire

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of the second annual “Closing the Gap: CRC Screening Insights” ...